Takeda signs MoU with BIRAC to support healthcare start-ups EP News Bureau Dec 5, 2023 Besides supporting healthcare startups, the partnership will also contribute to India’s aspiration of emerging as a $300 billion…
DCGI gives EUA to India’s first nasal vaccine against COVID-19 Press Information Bureau Sep 7, 2022 BBV154 is an intra-nasal replication-deficient chimpanzee adenovirus SARS-CoV-2 vectored vaccine
IDRS Labs seeks emergency nod for plant-based drug against long COVID EP News Bureau Aug 31, 2022 A tripartite Memorandum of Agreement was signed among BARC, ACTREC-TMC and IDRS to develop Chlorophyllin against COVID-19 disease…
Dr Jitendra Singh inaugurates north India’s first biotech park in Kathua Press Information Bureau May 30, 2022 Park to act as hub for incubation of new ideas, and will support agri-entrepreneurs, startups, progressive farmers, scientists and…
DBT and Ministry of AYUSH sign MoU Press Information Bureau May 26, 2022 Through this association, it is expected that traditional healthcare and biotechnology together would enable possibilities to…
Union Minister Dr Jitendra Singh launches BioRRAP for researchers and start-ups Press Information Bureau May 24, 2022 Speaking during the launch of Biological Research Regulatory Approval Portal (BioRRAP), Dr Singh said, India is poised to become a…
Fibroheal raises debt funding from BIRAC EP News Bureau Mar 19, 2022 The company intends to scale up its go-to-market capabilities, recruit more people on board and create an impact through the…
Dr Jyotsna Dhawan joins DBT/India Alliance as CEO EP News Bureau Dec 7, 2021 She has taken over responsibilities from Dr Vasan Sambandamurthy with effect from 1st December, 2021 till further communication
India and Colombia exchange views on cooperation in biotechnology sector and vaccine tie-up Press Trust of India Oct 4, 2021 A high-level delegation from Colombia led by Marta Lucia Ramirez de Rincón, Vice-President and Minister, Foreign Affairs, visited…
India’s first COVID-19 mRNA vaccine developed in partnership with DBT-BIRAC Press Information Bureau Aug 25, 2021 The Vaccine Subject Expert Committee (SEC) reviewed the interim phase-I data and found that HGCO19 was safe, tolerable and…